APP Recommends Filtering Contaminated Fluorouracil Lots
This article was originally published in The Pink Sheet Daily
Executive Summary
American Pharmaceutical Partners has issued a recall due to a potential for the presence of invisible glass particles in the injectable chemotherapeutic, but it will continue to distribute the affected lots to avoid shortage.